UBS Group’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $18.3M | Sell |
|
|||||
|
2025
Q2 | $23.4M | Sell |
|
|||||
|
2025
Q1 | $29.5M | Buy |
|
|||||
|
2024
Q4 | $20.3M | Buy |
|
|||||
|
2024
Q3 | $5.27M | Sell |
|
|||||
|
2024
Q2 | $12.4M | Buy |
|
|||||
|
2024
Q1 | $6.7M | Sell |
|
|||||
|
2023
Q4 | $6.82M | Buy |
|
|||||
|
2023
Q3 | $2.62M | Buy |
|
|||||
|
2023
Q2 | $1.26M | Sell |
|
|||||
|
2023
Q1 | $1.13M | Sell |
|
|||||
|
2022
Q4 | $2.79M | Buy |
|
|||||
|
2022
Q3 | $196K | Buy |
|
|||||
|
2022
Q2 | $41K | Sell |
|
|||||
|
2022
Q1 | $49K | Sell |
|
|||||
|
2021
Q4 | $4.44M | Buy |
|
|||||
|
2021
Q3 | $1.64M | Buy |
|
|||||
|
2021
Q2 | $26K | Buy |
|